Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability

被引:21
作者
Tong, YS [1 ]
Lin, NH [1 ]
Wang, L [1 ]
Hasvold, L [1 ]
Wang, WB [1 ]
Leonard, N [1 ]
Li, TM [1 ]
Li, Q [1 ]
Cohen, J [1 ]
Gu, WZ [1 ]
Zhang, HY [1 ]
Stoll, V [1 ]
Bauch, J [1 ]
Marsh, K [1 ]
Rosenberg, SH [1 ]
Sham, HL [1 ]
机构
[1] Abbott Labs, Global Pharmaceut R&D, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/S0960-894X(03)00195-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A pyridyl moiety was introduced into a previously developed series of farnesyltransferase inhibitors containing imidazole and cyanophenyl (such as 4), resulting in potent inhibitors with improved pharmacokinetics. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1571 / 1574
页数:4
相关论文
共 14 条
[1]   Protein farnesyltransferase inhibitors [J].
Ayral-Kaloustian, S ;
Salaski, EJ .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (10) :1003-1032
[2]   Farnesyl protein transferase inhibitors and other therapies targeting the ras signal transduction pathway [J].
End, DW .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) :241-258
[3]  
GOTLIB J, 2002, PROGR P 38 AM SOC CL
[4]   Oncoprotein networks [J].
Hunter, T .
CELL, 1997, 88 (03) :333-346
[5]   Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB [J].
Lebowitz, PF ;
Casey, PJ ;
Prendergast, GC ;
Thissen, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) :15591-15594
[6]  
Lobell RB, 2001, CANCER RES, V61, P8758
[7]   Iminophosphorane-mediated synthesis of 1-acyl-beta-carbolines: A new access to the alkaloids eudistomin T, S and xestomanzamine A of marine origin [J].
Molina, P ;
Fresneda, PM ;
GarciaZafra, S .
TETRAHEDRON LETTERS, 1996, 37 (52) :9353-9356
[8]   Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects [J].
Prendergast, GC .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :166-173
[9]  
Qian YM, 1997, BIOPOLYMERS, V43, P25, DOI 10.1002/(SICI)1097-0282(1997)43:1<25::AID-BIP4>3.0.CO
[10]  
2-2